Nonvariceal Upper Gastrointestinal Bleeding

Gastroduodenal ulcerations still account for the majority of nonvariceal gastrointestinal hemorrhage. The causative roles of Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) are still being discussed, but the role of H. pylori appears less significant in the complicated ulcers, while NSAIDs are increasingly implicated. The two factors do not appear to potentiate each other, and some data suggest that H. pylori should not be eradicated in the context of an NSAID-related ulcer hemorrhage.

The role of triage and risk assessment was highlighted in several of last year's publications, and increasing attention has been given to the cost aspects of peptic ulcer bleeding.

There have been few comparative therapeutic trials, but several reports from Japan make a case for ethanol injection as an alternative to other injection agents. However, a randomized comparative trial is needed to further define the role of this technique. Radiological embolization techniques and minimally invasive surgery are increasingly becoming viable options in patients with complex cases, and a multidisciplinary approach is perhaps even more crucial today than ever before.

References

• 1 Palmer K R. Ulcers and nonvariceal bleeding.  Endoscopy. 2000;  32 118-123
• 2 Al-Mishlab T, Amin A M, Ellul J P. Dieulafoy's lesion: an obscure cause of GI bleeding.  J R Coll Surg Edinb. 1999;  44 222-225
• 3 Di Liberato L, Sirolli V, Lattanzio R, et al. Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients.  Int J Artif Organs. 1999;  22 488-491
• 4 Nozoe T, Kitamura M, Matsumata T, et al. Dieulafoy-like lesions of colon and rectum in patients with chronic renal failure on long-term hemodialysis.  Hepatogastroenterology. 1999;  46 3121-3123
• 5 Kjeldsen A D, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.  Am J Gastroenterol. 2000;  95 415-418
• 6 Chiu E J, Shyr Y M, Su C H, et al. Diverticular disease of the small bowel.  Hepatogastroenterology. 2000;  47 181-184
• 7 Pennazio M, Arrigoni A, Rossini F P. Enteroscopic identification of an adenocarcinoma of the small bowel in a patient with previously unrecognized hereditary nonpolyposis colorectal cancer syndrome.  Am J Gastroenterol. 1999;  94 1962-1966
• 8 Saito K, Koizumi K, Goto Y, et al. Localization of small bowel bleeding by arterial injection of Tc-99m-labeled RBC.  Ann Nucl Med. 1999;  13 191-194
• 9 Testori A, Orsi F, Mazzarol G, et al. Rare presentation of small bowel leiomyosarcoma with liver metastases.  J Exp Clin Cancer Res. 1999;  18 439-441
• 10 Wong L S, Boughli I, Odogwu S, et al. Metastatic melanoma of the small bowel as a cause of occult intestinal bleeding.  J R Coll Surg Edinb. 1999;  44 341-343
• 11 Watanabe T, Kudo M, Kayaba M, et al. Massive rectal bleeding due to ileal tuberculosis.  J Gastroenterol. 1999;  34 525-529
• 12 Ajayi N A, Marven S, Kaschula R O, et al. Intestinal ulceration, obstruction, and haemorrhage in congenital syphilis.  Pediatr Surg Int. 1999;  15 391-393
• 13 Kuyvenhoven J P, Veenendaal R A, Vandenbroucke J P. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.  Scand J Gastroenterol. 1999;  34 1082-1086
• 14 Aalykke C, Lauritsen J M, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.  Gastroenterology. 1999;  116 1305-1309
• 15 Santolaria S, Lanas A, Benito R, et al. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users.  Aliment Pharmacol Ther. 1999;  13 1511-1518
• 16 Hawkey C J. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.  Gut. 2000;  46 310-311
• 17 Ng T M, Fock K M, Khor J L, et al. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.  Aliment Pharmacol Ther. 2000;  14 203-209
• 18 Colin R, Czernichow P, Baty V, et al. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer.  Gastroenterol Clin Biol. 2000;  24 31-35
• 19 Lee J M, Breslin N P, Fallon C, et al. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding.  Am J Gastroenterol. 2000;  95 1166-1170
• 20 Lin H J, Tseng G Y, Hsieh Y H, et al. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?.  Am J Gastroenterol. 1999;  94 3184-3188
• 21 Langman M J, Jensen D M, Watson D J, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.  JAMA. 1999;  282 1929-1933
• 22 Goldenberg M M. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.  Clin Ther. 1999;  21 1497-1513
• 23 Hawkey C, Laine L, Simon T, et al. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group.  Arthritis Rheum. 2000;  43 370-377
• 24 Weil J, Langman M J, Wainwright P, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.  Gut. 2000;  46 27-31
• 25 Cheatum D E, Arvanitakis C, Gumpel M, et al. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.  Clin Ther. 1999;  21 992-1003
• 26 Bourienne A, Pagenault M, Heresbach D, et al. Prospective multicenter study of prognostic factors in peptic ulcer bleeding: reassessment of clinical and endoscopic data at the era of endoscopic hemostasis.  Gastroenterol Clin Biol. 2000;  2 193-200
• 27 Cook D, Heyland D, Griffith L, et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation.  Canadian Critical Care Trials Group.. Crit Care Med. 1999;  27 2812-2817
• 28 Lewis J D, Shin E J, Metz D C. Characterization of gastrointestinal bleeding in severely ill hospitalized patients.  Crit Care Med. 2000;  28 46-50
• 29 Afessa B. Triage of patients with acute gastrointestinal bleeding for intensive care unit admission based on risk factors for poor outcome.  J Clin Gastroenterol. 2000;  30 281-285
• 30 Marshall J K, Collins S M, Gafni A. Demographic predictors of resource utilization for bleeding peptic ulcer disease: the Ontario GI Bleed Study.  J Clin Gastroenterol. 1999;  29 165-170
• 31 Marshall J K, Collins S M, Gafni A. Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a Canadian community hospital.  Am J Gastroenterol. 1999;  94 1841-1846
• 32 Cattaruzzi C, Troncon M G, Agostinis L, et al. Positive predictive value of ICD-9 codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database.  J Clin Epidemiol. 1999;  52 499-502
• 33 Cooper G S, Chak A, Lloyd L E, et al. The accuracy of diagnosis and procedural codes for patients with upper GI hemorrhage.  Gastrointest Endosc. 2000;  51 423-426
• 34 Chung Y F, Wong W K, Soo K C. Diagnostic failures in endoscopy for acute upper gastrointestinal haemorrhage.  Br J Surg. 2000;  87 614-617
• 35 Rutgeerts P, Rauws E, Wara P, et al. Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.  Lancet. 1997;  350 692-696
• 36 Messmann H, Schaller P, Andus T, et al. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.  Endoscopy. 1998;  30 583-589
• 37 Dunn C J, Goa K L. Fibrin sealant: a review of its use in surgery and endoscopy.  Drugs. 1999;  58 863-866
• 38 Asaki S. Efficacy of endoscopic pure ethanol injection method for gastrointestinal ulcer bleeding.  World J Surg. 2000;  24 294-298
• 39 Nagayama K, Tazawa J, Sakai Y, et al. Efficacy of endoscopic clipping for bleeding gastroduodenal ulcer: comparison with topical ethanol injection.  Am J Gastroenterol. 1999;  94 2897-2901
• 40 Tatemichi M, Nagata H, Sekizuka E, et al. Is endoscopic paravascular injection of sclerosing agents reasonable in the control of GI bleeding?.  Gastrointest Endosc. 1999;  50 499-505
• 41 Tanabe S, Koizumi W, Imaizumi H, et al. The management of bleeding peptic ulcer in the elderly with heater probe thermocoagulation.  Hepatogastroenterology. 1999;  46 3004-3007
• 42 Cipolletta L, Bianco M A, Rotondano G, et al. Prospective comparison of argon plasma coagulator and heater probe in the endoscopic treatment of major peptic ulcer bleeding.  Gastrointest Endosc. 1998;  48 191-195
• 43 Parra-Blanco A, Kaminaga N, Kojima T, et al. Hemoclipping for postpolypectomy and postbiopsy colonic bleeding.  Gastrointest Endosc. 2000;  51 37-41
• 44 Abi-Hanna D, Williams S J, Gillespie P E, et al. Endoscopic band ligation for non-variceal non-ulcer gastrointestinal hemorrhage.  Gastrointest Endosc. 1998;  48 510-514
• 45 Wong R M, Ota S, Katoh A, et al. Endoscopic ligation for non-esophageal variceal upper gastrointestinal hemorrhage.  Endoscopy. 1998;  30 774-777
• 46 Satoh T, Shimoyama T, Fukuda S, et al. Simple hemostatic procedure for hemorrhagic duodenal ulcer: two cases of arterial hemorrhage quickly controlled by balloon compression.  Endoscopy. 2000;  32 84-86
• 47 Daneshmend T K, Hawkey C J, Langman M J, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.  Br Med J. 1992;  304 143-147
• 48 Barkun A N, Cockeram A W, Plourde V, et al. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.  Aliment Pharmacol Ther. 1999;  13 1565-1584
• 49 Tseng G Y, Lin H J, Lin H Y, et al. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy: a prospective randomized comparative trial.  Hepatogastroenterology. 1999;  46 2183-2208
• 50 Bustamante M, Stollman N. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.  J Clin Gastroenterol. 2000;  30 7-13
• 51 Luchtefeld M A, Senagore A J, Szomstein M, et al. Evaluation of transarterial embolization for lower gastrointestinal bleeding.  Dis Colon Rectum. 2000;  43 532-534
• 52 Carreira J M, Reyes R, Pulido-Duque J M, et al. Diagnosis and percutaneous treatment of gastrointestinal hemorrhage: long-term experience.  Rev Esp Enferm Dig. 1999;  91 684-692
• 53 Imaizumi H, Mitsuhashi T, Hirata M, et al. A giant intramural gastric hematoma successfully treated by transcatheter arterial embolization.  Intern Med. 2000;  39 231-234
• 54 Ishigami K, Yoshimitsu K, Honda H, et al. Coil embolization of arterioportal fistula that developed after partial gastrectomy.  Cardiovasc Intervent Radiol. 1999;  22 328-330
• 55 Ledermann H P, Schoch E, Jost R, et al. Embolization of the vasa recta in acute lower gastrointestinal hemorrhage: a report of five cases.  Cardiovasc Intervent Radiol. 1999;  22 315-320
• 56 Bulakbasi N, Kurtaran K, Ustunsoz B, et al. Massive lower gastrointestinal hemorrhage from the surgical anastomosis in patients with multiorgan trauma: treatment by subselective embolization with polyvinyl alcohol particles.  Cardiovasc Intervent Radiol. 1999;  22 461-467
• 57 Hannon J K, Snow L L, Weinstein L S, Lane D R. Balloon-tipped cannulas for use in laparoscopic diagnosis and treatment of acute upper GI bleeding.  Surg Endosc. 2000;  14 123-126